 | • レポートコード：MRC2-11QY04047 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は腫瘍学分子診断のグローバル市場について調査・分析したレポートです。種類別（機器、試薬）市場規模、用途別（乳がん、前立腺がん、結腸直腸がん、子宮頸がん、肝臓がん、肺がん、血液がん、腎臓がん）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別腫瘍学分子診断の競争状況、市場シェア ・世界の腫瘍学分子診断市場：種類別市場規模 2015年-2020年（機器、試薬） ・世界の腫瘍学分子診断市場：種類別市場規模予測 2021年-2026年（機器、試薬） ・世界の腫瘍学分子診断市場：用途別市場規模 2015年-2020年（乳がん、前立腺がん、結腸直腸がん、子宮頸がん、肝臓がん、肺がん、血液がん、腎臓がん） ・世界の腫瘍学分子診断市場：用途別市場規模予測 2021年-2026年（乳がん、前立腺がん、結腸直腸がん、子宮頸がん、肝臓がん、肺がん、血液がん、腎臓がん） ・北米の腫瘍学分子診断市場分析：米国、カナダ ・ヨーロッパの腫瘍学分子診断市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの腫瘍学分子診断市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の腫瘍学分子診断市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの腫瘍学分子診断市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Bayer Healthcare、Beckton Dickinson、Cepheid、Dako、Danaher Corporation、Gen Probe、Qiagen、Roche Diagnostics、Siemens Healthineers、Sysmex Corporation ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Oncology Based Molecular Diagnostic Market
The global Oncology Based Molecular Diagnostic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Oncology Based Molecular Diagnostic Scope and Market Size
Oncology Based Molecular Diagnostic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oncology Based Molecular Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories
Bayer Healthcare
Beckton Dickinson
Cepheid
Dako
Danaher Corporation
Gen Probe
Qiagen
Roche Diagnostics
Siemens Healthineers
Sysmex Corporation
Market segment by Type, the product can be split into
Instruments
Reagents
Market segment by Application, split into
Breast Cancer
Prostate Cancer
Colorectal Cancer
Cervical Cancer
Liver Cancer
Lung Cancer
Blood Cancer
Kidney Cancer
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Oncology Based Molecular Diagnostic Revenue
1.4 Market by Type
1.4.1 Global Oncology Based Molecular Diagnostic Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Instruments
1.4.3 Reagents
1.5 Market by Application
1.5.1 Global Oncology Based Molecular Diagnostic Market Share by Application: 2020 VS 2026
1.5.2 Breast Cancer
1.5.3 Prostate Cancer
1.5.4 Colorectal Cancer
1.5.5 Cervical Cancer
1.5.6 Liver Cancer
1.5.7 Lung Cancer
1.5.8 Blood Cancer
1.5.9 Kidney Cancer
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Oncology Based Molecular Diagnostic Market Perspective (2015-2026)
2.2 Global Oncology Based Molecular Diagnostic Growth Trends by Regions
2.2.1 Oncology Based Molecular Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Oncology Based Molecular Diagnostic Historic Market Share by Regions (2015-2020)
2.2.3 Oncology Based Molecular Diagnostic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Oncology Based Molecular Diagnostic Market Growth Strategy
2.3.6 Primary Interviews with Key Oncology Based Molecular Diagnostic Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Oncology Based Molecular Diagnostic Players by Market Size
3.1.1 Global Top Oncology Based Molecular Diagnostic Players by Revenue (2015-2020)
3.1.2 Global Oncology Based Molecular Diagnostic Revenue Market Share by Players (2015-2020)
3.1.3 Global Oncology Based Molecular Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Oncology Based Molecular Diagnostic Market Concentration Ratio
3.2.1 Global Oncology Based Molecular Diagnostic Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Oncology Based Molecular Diagnostic Revenue in 2019
3.3 Oncology Based Molecular Diagnostic Key Players Head office and Area Served
3.4 Key Players Oncology Based Molecular Diagnostic Product Solution and Service
3.5 Date of Enter into Oncology Based Molecular Diagnostic Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Oncology Based Molecular Diagnostic Historic Market Size by Type (2015-2020)
4.2 Global Oncology Based Molecular Diagnostic Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Oncology Based Molecular Diagnostic Market Size by Application (2015-2020)
5.2 Global Oncology Based Molecular Diagnostic Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Oncology Based Molecular Diagnostic Market Size (2015-2020)
6.2 Oncology Based Molecular Diagnostic Key Players in North America (2019-2020)
6.3 North America Oncology Based Molecular Diagnostic Market Size by Type (2015-2020)
6.4 North America Oncology Based Molecular Diagnostic Market Size by Application (2015-2020)
7 Europe
7.1 Europe Oncology Based Molecular Diagnostic Market Size (2015-2020)
7.2 Oncology Based Molecular Diagnostic Key Players in Europe (2019-2020)
7.3 Europe Oncology Based Molecular Diagnostic Market Size by Type (2015-2020)
7.4 Europe Oncology Based Molecular Diagnostic Market Size by Application (2015-2020)
8 China
8.1 China Oncology Based Molecular Diagnostic Market Size (2015-2020)
8.2 Oncology Based Molecular Diagnostic Key Players in China (2019-2020)
8.3 China Oncology Based Molecular Diagnostic Market Size by Type (2015-2020)
8.4 China Oncology Based Molecular Diagnostic Market Size by Application (2015-2020)
9 Japan
9.1 Japan Oncology Based Molecular Diagnostic Market Size (2015-2020)
9.2 Oncology Based Molecular Diagnostic Key Players in Japan (2019-2020)
9.3 Japan Oncology Based Molecular Diagnostic Market Size by Type (2015-2020)
9.4 Japan Oncology Based Molecular Diagnostic Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Oncology Based Molecular Diagnostic Market Size (2015-2020)
10.2 Oncology Based Molecular Diagnostic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Oncology Based Molecular Diagnostic Market Size by Type (2015-2020)
10.4 Southeast Asia Oncology Based Molecular Diagnostic Market Size by Application (2015-2020)
11 India
11.1 India Oncology Based Molecular Diagnostic Market Size (2015-2020)
11.2 Oncology Based Molecular Diagnostic Key Players in India (2019-2020)
11.3 India Oncology Based Molecular Diagnostic Market Size by Type (2015-2020)
11.4 India Oncology Based Molecular Diagnostic Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Oncology Based Molecular Diagnostic Market Size (2015-2020)
12.2 Oncology Based Molecular Diagnostic Key Players in Central & South America (2019-2020)
12.3 Central & South America Oncology Based Molecular Diagnostic Market Size by Type (2015-2020)
12.4 Central & South America Oncology Based Molecular Diagnostic Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories Oncology Based Molecular Diagnostic Introduction
13.1.4 Abbott Laboratories Revenue in Oncology Based Molecular Diagnostic Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Bayer Healthcare
13.2.1 Bayer Healthcare Company Details
13.2.2 Bayer Healthcare Business Overview
13.2.3 Bayer Healthcare Oncology Based Molecular Diagnostic Introduction
13.2.4 Bayer Healthcare Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
13.2.5 Bayer Healthcare Recent Development
13.3 Beckton Dickinson
13.3.1 Beckton Dickinson Company Details
13.3.2 Beckton Dickinson Business Overview
13.3.3 Beckton Dickinson Oncology Based Molecular Diagnostic Introduction
13.3.4 Beckton Dickinson Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
13.3.5 Beckton Dickinson Recent Development
13.4 Cepheid
13.4.1 Cepheid Company Details
13.4.2 Cepheid Business Overview
13.4.3 Cepheid Oncology Based Molecular Diagnostic Introduction
13.4.4 Cepheid Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
13.4.5 Cepheid Recent Development
13.5 Dako
13.5.1 Dako Company Details
13.5.2 Dako Business Overview
13.5.3 Dako Oncology Based Molecular Diagnostic Introduction
13.5.4 Dako Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
13.5.5 Dako Recent Development
13.6 Danaher Corporation
13.6.1 Danaher Corporation Company Details
13.6.2 Danaher Corporation Business Overview
13.6.3 Danaher Corporation Oncology Based Molecular Diagnostic Introduction
13.6.4 Danaher Corporation Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
13.6.5 Danaher Corporation Recent Development
13.7 Gen Probe
13.7.1 Gen Probe Company Details
13.7.2 Gen Probe Business Overview
13.7.3 Gen Probe Oncology Based Molecular Diagnostic Introduction
13.7.4 Gen Probe Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
13.7.5 Gen Probe Recent Development
13.8 Qiagen
13.8.1 Qiagen Company Details
13.8.2 Qiagen Business Overview
13.8.3 Qiagen Oncology Based Molecular Diagnostic Introduction
13.8.4 Qiagen Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
13.8.5 Qiagen Recent Development
13.9 Roche Diagnostics
13.9.1 Roche Diagnostics Company Details
13.9.2 Roche Diagnostics Business Overview
13.9.3 Roche Diagnostics Oncology Based Molecular Diagnostic Introduction
13.9.4 Roche Diagnostics Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
13.9.5 Roche Diagnostics Recent Development
13.10 Siemens Healthineers
13.10.1 Siemens Healthineers Company Details
13.10.2 Siemens Healthineers Business Overview
13.10.3 Siemens Healthineers Oncology Based Molecular Diagnostic Introduction
13.10.4 Siemens Healthineers Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
13.10.5 Siemens Healthineers Recent Development
13.11 Sysmex Corporation
10.11.1 Sysmex Corporation Company Details
10.11.2 Sysmex Corporation Business Overview
10.11.3 Sysmex Corporation Oncology Based Molecular Diagnostic Introduction
10.11.4 Sysmex Corporation Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
10.11.5 Sysmex Corporation Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Oncology Based Molecular Diagnostic Key Market Segments
Table 2. Key Players Covered: Ranking by Oncology Based Molecular Diagnostic Revenue
Table 3. Ranking of Global Top Oncology Based Molecular Diagnostic Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Oncology Based Molecular Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Instruments
Table 6. Key Players of Reagents
Table 7. Global Oncology Based Molecular Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Oncology Based Molecular Diagnostic Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Oncology Based Molecular Diagnostic Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Oncology Based Molecular Diagnostic Market Share by Regions (2015-2020)
Table 11. Global Oncology Based Molecular Diagnostic Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Oncology Based Molecular Diagnostic Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Oncology Based Molecular Diagnostic Market Growth Strategy
Table 17. Main Points Interviewed from Key Oncology Based Molecular Diagnostic Players
Table 18. Global Oncology Based Molecular Diagnostic Revenue by Players (2015-2020) (Million US$)
Table 19. Global Oncology Based Molecular Diagnostic Market Share by Players (2015-2020)
Table 20. Global Top Oncology Based Molecular Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Based Molecular Diagnostic as of 2019)
Table 21. Global Oncology Based Molecular Diagnostic by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Oncology Based Molecular Diagnostic Product Solution and Service
Table 24. Date of Enter into Oncology Based Molecular Diagnostic Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oncology Based Molecular Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 27. Global Oncology Based Molecular Diagnostic Market Size Share by Type (2015-2020)
Table 28. Global Oncology Based Molecular Diagnostic Revenue Market Share by Type (2021-2026)
Table 29. Global Oncology Based Molecular Diagnostic Market Size Share by Application (2015-2020)
Table 30. Global Oncology Based Molecular Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 31. Global Oncology Based Molecular Diagnostic Market Size Share by Application (2021-2026)
Table 32. North America Key Players Oncology Based Molecular Diagnostic Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Oncology Based Molecular Diagnostic Market Share (2019-2020)
Table 34. North America Oncology Based Molecular Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 35. North America Oncology Based Molecular Diagnostic Market Share by Type (2015-2020)
Table 36. North America Oncology Based Molecular Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 37. North America Oncology Based Molecular Diagnostic Market Share by Application (2015-2020)
Table 38. Europe Key Players Oncology Based Molecular Diagnostic Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Oncology Based Molecular Diagnostic Market Share (2019-2020)
Table 40. Europe Oncology Based Molecular Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Oncology Based Molecular Diagnostic Market Share by Type (2015-2020)
Table 42. Europe Oncology Based Molecular Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Oncology Based Molecular Diagnostic Market Share by Application (2015-2020)
Table 44. China Key Players Oncology Based Molecular Diagnostic Revenue (2019-2020) (Million US$)
Table 45. China Key Players Oncology Based Molecular Diagnostic Market Share (2019-2020)
Table 46. China Oncology Based Molecular Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 47. China Oncology Based Molecular Diagnostic Market Share by Type (2015-2020)
Table 48. China Oncology Based Molecular Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 49. China Oncology Based Molecular Diagnostic Market Share by Application (2015-2020)
Table 50. Japan Key Players Oncology Based Molecular Diagnostic Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Oncology Based Molecular Diagnostic Market Share (2019-2020)
Table 52. Japan Oncology Based Molecular Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Oncology Based Molecular Diagnostic Market Share by Type (2015-2020)
Table 54. Japan Oncology Based Molecular Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Oncology Based Molecular Diagnostic Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Oncology Based Molecular Diagnostic Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Oncology Based Molecular Diagnostic Market Share (2019-2020)
Table 58. Southeast Asia Oncology Based Molecular Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Oncology Based Molecular Diagnostic Market Share by Type (2015-2020)
Table 60. Southeast Asia Oncology Based Molecular Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Oncology Based Molecular Diagnostic Market Share by Application (2015-2020)
Table 62. India Key Players Oncology Based Molecular Diagnostic Revenue (2019-2020) (Million US$)
Table 63. India Key Players Oncology Based Molecular Diagnostic Market Share (2019-2020)
Table 64. India Oncology Based Molecular Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 65. India Oncology Based Molecular Diagnostic Market Share by Type (2015-2020)
Table 66. India Oncology Based Molecular Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 67. India Oncology Based Molecular Diagnostic Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Oncology Based Molecular Diagnostic Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Oncology Based Molecular Diagnostic Market Share (2019-2020)
Table 70. Central & South America Oncology Based Molecular Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Oncology Based Molecular Diagnostic Market Share by Type (2015-2020)
Table 72. Central & South America Oncology Based Molecular Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Oncology Based Molecular Diagnostic Market Share by Application (2015-2020)
Table 74. Abbott Laboratories Company Details
Table 75. Abbott Laboratories Business Overview
Table 76. Abbott Laboratories Product
Table 77. Abbott Laboratories Revenue in Oncology Based Molecular Diagnostic Business (2015-2020) (Million US$)
Table 78. Abbott Laboratories Recent Development
Table 79. Bayer Healthcare Company Details
Table 80. Bayer Healthcare Business Overview
Table 81. Bayer Healthcare Product
Table 82. Bayer Healthcare Revenue in Oncology Based Molecular Diagnostic Business (2015-2020) (Million US$)
Table 83. Bayer Healthcare Recent Development
Table 84. Beckton Dickinson Company Details
Table 85. Beckton Dickinson Business Overview
Table 86. Beckton Dickinson Product
Table 87. Beckton Dickinson Revenue in Oncology Based Molecular Diagnostic Business (2015-2020) (Million US$)
Table 88. Beckton Dickinson Recent Development
Table 89. Cepheid Company Details
Table 90. Cepheid Business Overview
Table 91. Cepheid Product
Table 92. Cepheid Revenue in Oncology Based Molecular Diagnostic Business (2015-2020) (Million US$)
Table 93. Cepheid Recent Development
Table 94. Dako Company Details
Table 95. Dako Business Overview
Table 96. Dako Product
Table 97. Dako Revenue in Oncology Based Molecular Diagnostic Business (2015-2020) (Million US$)
Table 98. Dako Recent Development
Table 99. Danaher Corporation Company Details
Table 100. Danaher Corporation Business Overview
Table 101. Danaher Corporation Product
Table 102. Danaher Corporation Revenue in Oncology Based Molecular Diagnostic Business (2015-2020) (Million US$)
Table 103. Danaher Corporation Recent Development
Table 104. Gen Probe Company Details
Table 105. Gen Probe Business Overview
Table 106. Gen Probe Product
Table 107. Gen Probe Revenue in Oncology Based Molecular Diagnostic Business (2015-2020) (Million US$)
Table 108. Gen Probe Recent Development
Table 109. Qiagen Business Overview
Table 110. Qiagen Product
Table 111. Qiagen Company Details
Table 112. Qiagen Revenue in Oncology Based Molecular Diagnostic Business (2015-2020) (Million US$)
Table 113. Qiagen Recent Development
Table 114. Roche Diagnostics Company Details
Table 115. Roche Diagnostics Business Overview
Table 116. Roche Diagnostics Product
Table 117. Roche Diagnostics Revenue in Oncology Based Molecular Diagnostic Business (2015-2020) (Million US$)
Table 118. Roche Diagnostics Recent Development
Table 119. Siemens Healthineers Company Details
Table 120. Siemens Healthineers Business Overview
Table 121. Siemens Healthineers Product
Table 122. Siemens Healthineers Revenue in Oncology Based Molecular Diagnostic Business (2015-2020) (Million US$)
Table 123. Siemens Healthineers Recent Development
Table 124. Sysmex Corporation Company Details
Table 125. Sysmex Corporation Business Overview
Table 126. Sysmex Corporation Product
Table 127. Sysmex Corporation Revenue in Oncology Based Molecular Diagnostic Business (2015-2020) (Million US$)
Table 128. Sysmex Corporation Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncology Based Molecular Diagnostic Market Share by Type: 2020 VS 2026
Figure 2. Instruments Features
Figure 3. Reagents Features
Figure 4. Global Oncology Based Molecular Diagnostic Market Share by Application: 2020 VS 2026
Figure 5. Breast Cancer Case Studies
Figure 6. Prostate Cancer Case Studies
Figure 7. Colorectal Cancer Case Studies
Figure 8. Cervical Cancer Case Studies
Figure 9. Liver Cancer Case Studies
Figure 10. Lung Cancer Case Studies
Figure 11. Blood Cancer Case Studies
Figure 12. Kidney Cancer Case Studies
Figure 13. Oncology Based Molecular Diagnostic Report Years Considered
Figure 14. Global Oncology Based Molecular Diagnostic Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Oncology Based Molecular Diagnostic Market Share by Regions: 2020 VS 2026
Figure 16. Global Oncology Based Molecular Diagnostic Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Oncology Based Molecular Diagnostic Market Share by Players in 2019
Figure 19. Global Top Oncology Based Molecular Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Based Molecular Diagnostic as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Oncology Based Molecular Diagnostic Revenue in 2019
Figure 21. North America Oncology Based Molecular Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Oncology Based Molecular Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Oncology Based Molecular Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Oncology Based Molecular Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Oncology Based Molecular Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Oncology Based Molecular Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Oncology Based Molecular Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed
大腸がん診断の世界市場（～2026年） Fecal occult blood tests dominated the industry in 2016 owing to cost effectiveness and non-invasiveness as compared to colonoscopy and sigmoidoscopy. Immuno-FOB agglutination and Immuno-FOB ELISA tests are major revenue generating segments of fecal occult blood tests segment. Growing awareness alon…- 子宮頸がん診断検査の世界市場（～2026年） Market Analysis and Insights: Global Cervical Cancer Diagnostic Test Market The global Cervical Cancer Diagnostic Test market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…
- がん分子バイオマーカーの世界市場（～2026年） Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body.A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluid…
- 腫瘍学/がん治療薬の世界市場（～2026年） Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. Oncology Drugs is widely used For Blood Cancer, Breast Cancer, Gastroint…
- 転移性大腸癌手術の世界市場（～2026年） Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…